Skip to main content
Top
Published in: BMC Cancer 1/2014

Open Access 01-12-2014 | Research article

The association of time between diagnosis and major resection with poorer colorectal cancer survival: a retrospective cohort study

Authors: Maria Theresa Redaniel, Richard M Martin, Jane M Blazeby, Julia Wade, Mona Jeffreys

Published in: BMC Cancer | Issue 1/2014

Login to get access

Abstract

Background

Colorectal cancer survival in the UK is lower than in other developed countries, but the association of time interval between diagnosis and treatment on excess mortality remains unclear.

Methods

Using data from cancer registries in England, we identified 46,511 patients with localised colorectal cancer between 1996–2009, who were 15 years and older, and who underwent a major surgical resection within 62 days of diagnosis. We used relative survival and excess risk modeling to investigate the association of time between diagnosis and major resection (exposure) with survival (outcome).

Results

Compared to patients who had major resection within 25–38 days of diagnosis, patients with a shorter time interval between diagnosis and resection and those waiting longer for resection had higher excess mortality (Excess Hazards Ratio, EHR <25 vs 25–38 days: 1.50; 95% Confidence Interval, CI: 1.37 to 1.66; EHR 39–62 vs 25–38 days : 1.16; 95% CI: 1.04 to 1.29). Excess mortality was associated with age (EHR 75+ vs. 15–44 year olds: 2.62; 95% CI: 2.00 to 3.42) and deprivation (EHR most vs. least deprived: 1.27; 95% CI: 1.12 to 1.45), but time between diagnosis and resection did not explain these differences.

Conclusion

Within 62 days of diagnosis, a U-shaped association of time between diagnosis and major resection with excess mortality for localised colorectal cancer was evident. This indicates a complicated treatment pathway, particularly for patients who had resection earlier than 25 days, and requires further investigation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA: Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011, 377 (9760): 127-138. 10.1016/S0140-6736(10)62231-3.CrossRefPubMedPubMedCentral Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA: Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011, 377 (9760): 127-138. 10.1016/S0140-6736(10)62231-3.CrossRefPubMedPubMedCentral
2.
go back to reference Morris EJ, Sandin F, Lambert PC, Bray F, Klint A, Linklater K, Robinson D, Pahlman L, Holmberg L, Moller H: A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut. 2011, 60 (8): 1087-1093. 10.1136/gut.2010.229575.CrossRefPubMed Morris EJ, Sandin F, Lambert PC, Bray F, Klint A, Linklater K, Robinson D, Pahlman L, Holmberg L, Moller H: A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut. 2011, 60 (8): 1087-1093. 10.1136/gut.2010.229575.CrossRefPubMed
3.
go back to reference Gatta G, Capocaccia R, Sant M, Bell CM, Coebergh JW, Damhuis RA, Faivre J, Martinez-Garcia C, Pawlega J, PonzdeLeon M, Pottier D, Raverdy N, Williams EM, Berrino F: Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut. 2000, 47 (4): 533-538. 10.1136/gut.47.4.533.CrossRefPubMedPubMedCentral Gatta G, Capocaccia R, Sant M, Bell CM, Coebergh JW, Damhuis RA, Faivre J, Martinez-Garcia C, Pawlega J, PonzdeLeon M, Pottier D, Raverdy N, Williams EM, Berrino F: Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut. 2000, 47 (4): 533-538. 10.1136/gut.47.4.533.CrossRefPubMedPubMedCentral
4.
go back to reference Maringe C, Walters S, Rachet B, Butler J, Fields T, Finan P, Maxwell R, Nedrebo B, Pahlman L, Sjovall A, Spigelman A, Engholm G, Gavin A, Gjerstorff ML, Hatcher J, Johannesen TB, Morris E, McGahan CE, Tracey E, Turner D, Richards MA, Coleman MP, Group IMW: Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000–2007. Acta Oncol. 2013, 52 (5): 919-932. 10.3109/0284186X.2013.764008.CrossRefPubMed Maringe C, Walters S, Rachet B, Butler J, Fields T, Finan P, Maxwell R, Nedrebo B, Pahlman L, Sjovall A, Spigelman A, Engholm G, Gavin A, Gjerstorff ML, Hatcher J, Johannesen TB, Morris E, McGahan CE, Tracey E, Turner D, Richards MA, Coleman MP, Group IMW: Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000–2007. Acta Oncol. 2013, 52 (5): 919-932. 10.3109/0284186X.2013.764008.CrossRefPubMed
5.
go back to reference Rachet B, Ellis L, Maringe C, Chu T, Nur U, Quaresma M, Shah A, Walters S, Woods L, Forman D, Coleman MP: Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer. 2010, 103 (4): 446-453. 10.1038/sj.bjc.6605752.CrossRefPubMedPubMedCentral Rachet B, Ellis L, Maringe C, Chu T, Nur U, Quaresma M, Shah A, Walters S, Woods L, Forman D, Coleman MP: Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer. 2010, 103 (4): 446-453. 10.1038/sj.bjc.6605752.CrossRefPubMedPubMedCentral
6.
go back to reference Walters S, Quaresma M, Coleman MP, Gordon E, Forman D, Rachet B: Geographical variation in cancer survival in England, 1991–2006: an analysis by Cancer Network. J Epidemiol Community Health. 2011, 65 (11): 1044-1052. 10.1136/jech.2010.126656.CrossRefPubMedPubMedCentral Walters S, Quaresma M, Coleman MP, Gordon E, Forman D, Rachet B: Geographical variation in cancer survival in England, 1991–2006: an analysis by Cancer Network. J Epidemiol Community Health. 2011, 65 (11): 1044-1052. 10.1136/jech.2010.126656.CrossRefPubMedPubMedCentral
7.
go back to reference National Cancer Intelligence Network: Cancer Incidence and Survival By Major Ethnic Group, England, 2002–2006. 2009, London National Cancer Intelligence Network: Cancer Incidence and Survival By Major Ethnic Group, England, 2002–2006. 2009, London
8.
go back to reference Department of Health: The NHS Cancer Plan. 2000, London Department of Health: The NHS Cancer Plan. 2000, London
9.
go back to reference Department of Health: Cancer Reform Strategy. 2007, London Department of Health: Cancer Reform Strategy. 2007, London
10.
go back to reference Department of Health: Review of Cancer Waiting Times Standards. 2011, London Department of Health: Review of Cancer Waiting Times Standards. 2011, London
11.
go back to reference Ramos M, Esteva M, Cabeza E, Campillo C, Llobera J, Aguilo A: Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review. Eur J Cancer. 2007, 43 (17): 2467-2478. 10.1016/j.ejca.2007.08.023.CrossRefPubMed Ramos M, Esteva M, Cabeza E, Campillo C, Llobera J, Aguilo A: Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review. Eur J Cancer. 2007, 43 (17): 2467-2478. 10.1016/j.ejca.2007.08.023.CrossRefPubMed
12.
go back to reference Bosman F, Carneiro F, Hruban R, Theise N: Pathology and Genetics. Tumours of the Digestive System. 2010, Lyon, France: IARC Bosman F, Carneiro F, Hruban R, Theise N: Pathology and Genetics. Tumours of the Digestive System. 2010, Lyon, France: IARC
13.
go back to reference European Network of Cancer Registries: ENCR Definitions for the Coding of Basis of Diagnosis. 1997, Lyon, France European Network of Cancer Registries: ENCR Definitions for the Coding of Basis of Diagnosis. 1997, Lyon, France
14.
go back to reference National Cancer Intelligence Network: Major Surgical Resections, England, 2004–2006. 2011, London National Cancer Intelligence Network: Major Surgical Resections, England, 2004–2006. 2011, London
15.
go back to reference Department of Health: A Practical Guide to Ethnic Monitoring in the NHS and Social Care. 2005, London Department of Health: A Practical Guide to Ethnic Monitoring in the NHS and Social Care. 2005, London
16.
go back to reference Hospital Episode Statistics: How good is HES ethnic coding and where do the problems lie?. 2009, London: The Health and Social Care Information Centre Hospital Episode Statistics: How good is HES ethnic coding and where do the problems lie?. 2009, London: The Health and Social Care Information Centre
17.
go back to reference Noble M, McLennan D, Wilkinson K, Whitworth A, Barnes H, Dibben C: The English indices of deprivation 2007. 2008, London: Communities and Local Government Noble M, McLennan D, Wilkinson K, Whitworth A, Barnes H, Dibben C: The English indices of deprivation 2007. 2008, London: Communities and Local Government
18.
go back to reference Office of the Deputy Prime Minister: The English Indices of Deprivation 2004: Summary. 2004, London Office of the Deputy Prime Minister: The English Indices of Deprivation 2004: Summary. 2004, London
19.
go back to reference Department for Communities and Local Government: Tracking Economic and Child Income Deprivation 1999–2009. 2012, London Department for Communities and Local Government: Tracking Economic and Child Income Deprivation 1999–2009. 2012, London
20.
go back to reference Brenner H, Gefeller O, Hakulinen T: Period analysis for ‘up-to-date’ cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer. 2004, 40 (3): 326-335. 10.1016/j.ejca.2003.10.013.CrossRefPubMed Brenner H, Gefeller O, Hakulinen T: Period analysis for ‘up-to-date’ cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer. 2004, 40 (3): 326-335. 10.1016/j.ejca.2003.10.013.CrossRefPubMed
21.
go back to reference StataCorp: Stata statistical software: release 12. 2011, College Station, TX: StataCorp LP StataCorp: Stata statistical software: release 12. 2011, College Station, TX: StataCorp LP
22.
go back to reference Ederer F, Axtell LM, Cutler SJ: The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961, 6: 101-121.PubMed Ederer F, Axtell LM, Cutler SJ: The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961, 6: 101-121.PubMed
23.
go back to reference Cancer Research UK Cancer Survival Group: Life tables for England by sex, calendar period, region and deprivation. 2009, London: London School of Hygiene & Tropical Medicine Cancer Research UK Cancer Survival Group: Life tables for England by sex, calendar period, region and deprivation. 2009, London: London School of Hygiene & Tropical Medicine
24.
go back to reference Dickman PW, Sloggett A, Hills M, Hakulinen T: Regression models for relative survival. Stat Med. 2004, 23 (1): 51-64. 10.1002/sim.1597.CrossRefPubMed Dickman PW, Sloggett A, Hills M, Hakulinen T: Regression models for relative survival. Stat Med. 2004, 23 (1): 51-64. 10.1002/sim.1597.CrossRefPubMed
25.
go back to reference Nur U, Shack LG, Rachet B, Carpenter JR, Coleman MP: Modelling relative survival in the presence of incomplete data: a tutorial. Int J Epidemiol. 2010, 39 (1): 118-128. 10.1093/ije/dyp309.CrossRefPubMed Nur U, Shack LG, Rachet B, Carpenter JR, Coleman MP: Modelling relative survival in the presence of incomplete data: a tutorial. Int J Epidemiol. 2010, 39 (1): 118-128. 10.1093/ije/dyp309.CrossRefPubMed
26.
go back to reference Royston P: Multiple imputation of missing values: update of ice. Stata J. 2005, 5: 527-536. Royston P: Multiple imputation of missing values: update of ice. Stata J. 2005, 5: 527-536.
27.
go back to reference Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR: Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009, 338: b2393-10.1136/bmj.b2393.CrossRefPubMedPubMedCentral Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR: Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009, 338: b2393-10.1136/bmj.b2393.CrossRefPubMedPubMedCentral
29.
go back to reference Walters S, Maringe C, Butler J, Brierley JD, Rachet B, Coleman MP: Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership. Int J Cancer. 2013, 132 (3): 676-685. 10.1002/ijc.27651.CrossRefPubMed Walters S, Maringe C, Butler J, Brierley JD, Rachet B, Coleman MP: Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership. Int J Cancer. 2013, 132 (3): 676-685. 10.1002/ijc.27651.CrossRefPubMed
30.
go back to reference National Institute for Health and Clinical Excellence: The Diagnosis and Management of Colorectal Cancer, Volume CG131. 2011, England National Institute for Health and Clinical Excellence: The Diagnosis and Management of Colorectal Cancer, Volume CG131. 2011, England
31.
go back to reference National Collaborating Centre for Cancer (UK): The Diagnosis and Management of Colorectal Cancer, NICE Clinical Guidelines, No. 131. 2011, Cardiff National Collaborating Centre for Cancer (UK): The Diagnosis and Management of Colorectal Cancer, NICE Clinical Guidelines, No. 131. 2011, Cardiff
32.
go back to reference Quasar Collaborative G, Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, Kerr DJ: Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet. 2007, 370 (9604): 2020-2029. 10.1016/S0140-6736(07)61866-2.CrossRef Quasar Collaborative G, Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, Kerr DJ: Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet. 2007, 370 (9604): 2020-2029. 10.1016/S0140-6736(07)61866-2.CrossRef
33.
go back to reference Williams JG, Roberts SE, Ali MF, Cheung WY, Cohen DR, Demery G, Edwards A, Greer M, Hellier MD, Hutchings HA, Ip B, Longo MF, Russell IT, Snooks HA, Williams JC: Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. Gut. 2007, 56 (Suppl 1): 1-113.CrossRefPubMed Williams JG, Roberts SE, Ali MF, Cheung WY, Cohen DR, Demery G, Edwards A, Greer M, Hellier MD, Hutchings HA, Ip B, Longo MF, Russell IT, Snooks HA, Williams JC: Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. Gut. 2007, 56 (Suppl 1): 1-113.CrossRefPubMed
34.
go back to reference Meechan D, Gildea C, Hollingworth L, Richards MA, Riley D, Rubin G: Variation in use of the 2-week referral pathway for suspected cancer: a cross-sectional analysis. Br J Gen Pract. 2012, 62 (602): e590-e597. 10.3399/bjgp12X654551.CrossRefPubMedPubMedCentral Meechan D, Gildea C, Hollingworth L, Richards MA, Riley D, Rubin G: Variation in use of the 2-week referral pathway for suspected cancer: a cross-sectional analysis. Br J Gen Pract. 2012, 62 (602): e590-e597. 10.3399/bjgp12X654551.CrossRefPubMedPubMedCentral
35.
go back to reference Robertson R, Campbell NC, Smith S, Donnan PT, Sullivan F, Duffy R, Ritchie LD, Millar D, Cassidy J, Munro A: Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas. Br J Cancer. 2004, 90 (8): 1479-1485. 10.1038/sj.bjc.6601753.CrossRefPubMedPubMedCentral Robertson R, Campbell NC, Smith S, Donnan PT, Sullivan F, Duffy R, Ritchie LD, Millar D, Cassidy J, Munro A: Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas. Br J Cancer. 2004, 90 (8): 1479-1485. 10.1038/sj.bjc.6601753.CrossRefPubMedPubMedCentral
36.
go back to reference McPhail S, Elliss-Brookes L, Shelton J, Ives A, Greenslade M, Vernon S, Morris EJ, Richards M: Emergency presentation of cancer and short-term mortality. Br J Cancer. 2013, 109 (8): 2027-2034. 10.1038/bjc.2013.569.CrossRefPubMedPubMedCentral McPhail S, Elliss-Brookes L, Shelton J, Ives A, Greenslade M, Vernon S, Morris EJ, Richards M: Emergency presentation of cancer and short-term mortality. Br J Cancer. 2013, 109 (8): 2027-2034. 10.1038/bjc.2013.569.CrossRefPubMedPubMedCentral
37.
go back to reference Cheynel N, Cortet M, Lepage C, Benoit L, Faivre J, Bouvier AM: Trends in frequency and management of obstructing colorectal cancers in a well-defined population. Dis Colon Rectum. 2007, 50 (10): 1568-1575. 10.1007/s10350-007-9007-4.CrossRefPubMed Cheynel N, Cortet M, Lepage C, Benoit L, Faivre J, Bouvier AM: Trends in frequency and management of obstructing colorectal cancers in a well-defined population. Dis Colon Rectum. 2007, 50 (10): 1568-1575. 10.1007/s10350-007-9007-4.CrossRefPubMed
38.
go back to reference Cheynel N, Cortet M, Lepage C, Ortega-Debalon P, Faivre J, Bouvier AM: Incidence, patterns of failure, and prognosis of perforated colorectal cancers in a well-defined population. Dis Colon Rectum. 2009, 52 (3): 406-411. 10.1007/DCR.0b013e318197e351.CrossRefPubMed Cheynel N, Cortet M, Lepage C, Ortega-Debalon P, Faivre J, Bouvier AM: Incidence, patterns of failure, and prognosis of perforated colorectal cancers in a well-defined population. Dis Colon Rectum. 2009, 52 (3): 406-411. 10.1007/DCR.0b013e318197e351.CrossRefPubMed
39.
go back to reference Carlisle J, Swart M, Dawe EJ, Chadwick M: Factors associated with survival after resection of colorectal adenocarcinoma in 314 patients. Br J Anaesth. 2012, 108 (3): 430-435. 10.1093/bja/aer444.CrossRefPubMed Carlisle J, Swart M, Dawe EJ, Chadwick M: Factors associated with survival after resection of colorectal adenocarcinoma in 314 patients. Br J Anaesth. 2012, 108 (3): 430-435. 10.1093/bja/aer444.CrossRefPubMed
40.
go back to reference Morris EJ, Taylor EF, Thomas JD, Quirke P, Finan PJ, Coleman MP, Rachet B, Forman D: Thirty-day postoperative mortality after colorectal cancer surgery in England. Gut. 2011, 60 (6): 806-813. 10.1136/gut.2010.232181.CrossRefPubMed Morris EJ, Taylor EF, Thomas JD, Quirke P, Finan PJ, Coleman MP, Rachet B, Forman D: Thirty-day postoperative mortality after colorectal cancer surgery in England. Gut. 2011, 60 (6): 806-813. 10.1136/gut.2010.232181.CrossRefPubMed
41.
go back to reference Dotan E, Browner I, Hurria A, Denlinger C: Challenges in the management of older patients with colon cancer. J Natl Compr Canc Netw. 2012, 10 (2): 213-224. quiz 225PubMedPubMedCentral Dotan E, Browner I, Hurria A, Denlinger C: Challenges in the management of older patients with colon cancer. J Natl Compr Canc Netw. 2012, 10 (2): 213-224. quiz 225PubMedPubMedCentral
42.
go back to reference Raine R, Wong W, Scholes S, Ashton C, Obichere A, Ambler G: Social variations in access to hospital care for patients with colorectal, breast, and lung cancer between 1999 and 2006: retrospective analysis of hospital episode statistics. BMJ. 2010, 340: b5479-10.1136/bmj.b5479.CrossRefPubMedPubMedCentral Raine R, Wong W, Scholes S, Ashton C, Obichere A, Ambler G: Social variations in access to hospital care for patients with colorectal, breast, and lung cancer between 1999 and 2006: retrospective analysis of hospital episode statistics. BMJ. 2010, 340: b5479-10.1136/bmj.b5479.CrossRefPubMedPubMedCentral
43.
go back to reference Wrigley H, Roderick P, George S, Smith J, Mullee M, Goddard J: Inequalities in survival from colorectal cancer: a comparison of the impact of deprivation, treatment, and host factors on observed and cause specific survival. J Epidemiol Community Health. 2003, 57 (4): 301-309. 10.1136/jech.57.4.301.CrossRefPubMedPubMedCentral Wrigley H, Roderick P, George S, Smith J, Mullee M, Goddard J: Inequalities in survival from colorectal cancer: a comparison of the impact of deprivation, treatment, and host factors on observed and cause specific survival. J Epidemiol Community Health. 2003, 57 (4): 301-309. 10.1136/jech.57.4.301.CrossRefPubMedPubMedCentral
44.
go back to reference Lejeune C, Sassi F, Ellis L, Godward S, Mak V, Day M, Rachet B: Socio-economic disparities in access to treatment and their impact on colorectal cancer survival. Int J Epidemiol. 2010, 39 (3): 710-717. 10.1093/ije/dyq048.CrossRefPubMed Lejeune C, Sassi F, Ellis L, Godward S, Mak V, Day M, Rachet B: Socio-economic disparities in access to treatment and their impact on colorectal cancer survival. Int J Epidemiol. 2010, 39 (3): 710-717. 10.1093/ije/dyq048.CrossRefPubMed
45.
go back to reference Crawford SM, Sauerzapf V, Haynes R, Forman D, Jones AP: Social and geographical factors affecting access to treatment of colorectal cancer: a cancer registry study. BMJ Open. 2012, 2 (2): e000410-CrossRefPubMedPubMedCentral Crawford SM, Sauerzapf V, Haynes R, Forman D, Jones AP: Social and geographical factors affecting access to treatment of colorectal cancer: a cancer registry study. BMJ Open. 2012, 2 (2): e000410-CrossRefPubMedPubMedCentral
Metadata
Title
The association of time between diagnosis and major resection with poorer colorectal cancer survival: a retrospective cohort study
Authors
Maria Theresa Redaniel
Richard M Martin
Jane M Blazeby
Julia Wade
Mona Jeffreys
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2014
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-14-642

Other articles of this Issue 1/2014

BMC Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine